bendamustine hydrochloride has been researched along with Lymphocytopenia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, S; Koyama, D; Misawa, K; Sukegawa, M; Suzuki, M; Teshirogi, M; Tsunoda, S | 1 |
| Butera, J; Egan, P; MacKinnon, K; Margolis, J; McMahon, J; Ollila, T; Olszewski, AJ; Reagan, J; Rosati, V; Thomas, A; Yakirevich, I | 1 |
| Jaksic, O; Lucijanic, M | 1 |
| Iwasaki, H; Kadowaki, M; Matsushima, T; Minami, M; Takase, K; Yamasaki, S | 1 |
| Bingman, A; Carothers, S; Kraut, EH; Layman, RM; Lustberg, MB; Lynn, M; Mrozek, E; Ottman, S; Ramaswamy, B; Reinbolt, R; Ruppert, AS; Shapiro, CL; Wesolowski, R | 1 |
| Ito, S; Naohiro, M; Ohigashi, H; Shimono, J; Souichi, S; Teshima, T; Yutaka, T | 1 |
| Fukuhara, S; Kitahara, H; Kobayashi, Y; Maeshima, AM; Makita, S; Maruyama, D; Miyamoto, K; Munakata, W; Saito, H; Suzuki, T; Taniguchi, H; Tobinai, K | 1 |
| Gafter-Gvili, A; Polliack, A | 1 |
| Schrijvers, D; Vermorken, JB | 1 |
| Bremer, K | 1 |
2 review(s) available for bendamustine hydrochloride and Lymphocytopenia
| Article | Year |
|---|---|
Bendamustine associated immune suppression and infections during therapy of hematological malignancies.
Topics: Agammaglobulinemia; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Hematologic Neoplasms; Humans; Immune System; Immunosuppressive Agents; Infections; Lymphopenia | 2016 |
Phase I studies with bendamustine: an update.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Europe; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphopenia; Multiple Myeloma; Nitrogen Mustard Compounds; Research Design | 2002 |
3 trial(s) available for bendamustine hydrochloride and Lymphocytopenia
| Article | Year |
|---|---|
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bendamustine Hydrochloride; Humans; Ileus; Liposomes; Lymphoma, B-Cell; Lymphopenia; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Vincristine | 2022 |
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lymphopenia; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Quinazolines; Severity of Illness Index | 2013 |
High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Lymphopenia; Male; Maximum Tolerated Dose; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Prognosis; Remission Induction; Salvage Therapy; Survival Rate | 2002 |
5 other study(ies) available for bendamustine hydrochloride and Lymphocytopenia
| Article | Year |
|---|---|
Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine-rituximab therapy.
Topics: Agammaglobulinemia; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Immunoglobulin G; Lymphocyte Count; Lymphoma, Non-Hodgkin; Lymphopenia; Retrospective Studies; Rituximab | 2022 |
Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Immunoglobulins, Intravenous; Leukoencephalopathy, Progressive Multifocal; Lymphoma, Follicular; Lymphopenia; Magnetic Resonance Imaging; Maintenance Chemotherapy; Middle Aged; Plasmapheresis; Prednisone; Recurrence; Rituximab; Vincristine | 2020 |
Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Humans; Lymphoma, Follicular; Lymphopenia; Male; Middle Aged; Retrospective Studies; Risk Factors; Rituximab | 2022 |
Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Humans; Lymphocyte Count; Lymphoma; Lymphopenia; Maintenance Chemotherapy; Rituximab | 2015 |
Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Humans; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Lymphopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab | 2015 |